Physician profile
Steven J Brown
NPI 1356373054
$1,347.85
in general payments reported to CMS, 2019-2025
20 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $69.34 · 2021: $121 · 2022: $386 · 2023: $351 · 2024: $80.12 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $210.07 | 2021-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $200.01 | 2021-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $137.90 | 2019-2025 | |
| Davol INC. | $125.01 | 2023 | Arista Ah Flexitip |
| Intuitive Surgical, INC. | $111.44 | 2019-2022 | |
| Pfizer INC. | $110.57 | 2019-2023 | |
| Amag Pharmaceuticals, INC. | $69.37 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $64.42 | 2023-2025 | |
| Millicent US INC | $56.40 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Mycovia Pharmaceuticals, INC. | $54.45 | 2022-2023 | Vivjoa |
| Exact Sciences Corporation | $39.40 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Urovant Sciences INC | $38.29 | 2021-2022 | |
| Abbvie INC. | $33.30 | 2019-2022 | |
| Hologic Sales and Service, LLC | $23.21 | 2023 | Aptima |
| Lsi Solutions INC | $16.34 | 2024 | Fornisee |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $15.60 | 2022 | |
| Therapeuticsmd, INC. | $15.33 | 2022 | |
| Agile Therapeutics, INC. | $13.91 | 2024 | Twirla |
| Allergan, INC. | $12.83 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.